Hematologic Neoplasms: all 1,494 studies
Page 11 of 15. Open to participants first (438), then studies with results posted, then the rest; newest registration first within each.
- Dual PD-1 and JAK2 Inhibition in Hematological MalignanciesWithdrawnNCT04016116Phase 2
- A Clinical Study of Anti-CD19 Chimeric Antigen Receptor T-Cell Injection (CNCT19) in the Treatment of Cluster of Differentiation 19 (CD19) Positive Relapsed or Refractory B Cell MalignanciesStatus unknownNCT04011293Early Phase 1
- Composite Health Assessment Risk Model (CHARM) for Older Adults (BMT CTN 1704)CompletedNCT03992352
- MPH966 for Prevention of Graft-versus-host Disease After Allogeneic Hematopoietic Stem Cell TransplantationWithdrawnNCT03986086Phase 1/2
- Optimizing PTCy Dose and TimingActive, not recruitingNCT03983850Phase 1/2
- Nutrition Health Literacy of Cancer Patients and Their Support Networks.TerminatedNCT03978312
- Treosulfan-TMI Conditioning and Rapamycin GvHD Prophylaxis Before Allo-HSCTTerminatedNCT03963024Phase 1
- Phase II Trial in Elderly Patients With AML or MDS in Complete Remission Not Eligible for Allogenic TransplantCompletedNCT03961919Phase 2
- In Person and Mobile Health Coping Skills Training for Improving Symptom Management and Daily Steps in Hematopoietic Stem Cell Transplant PatientsCompletedNCT03960619Not applicable
- Cohort of Patients Over 70 Years of Age With Cancer and / or Hematological MalignancyStatus unknownNCT03960593
- Venetoclax and Selinexor in Treating Patients with Relapsed or Refractory High Risk Hematologic MalignanciesCompletedNCT03955783Phase 1
- An Open Label Navigational Investigation of Molecular Profile-Related Evidence Determining Individualized Cancer Therapy for Patients With Incurable Hematologic Malignancies (I-PREDICT Heme)TerminatedNCT03955276
- CBM588 in Improving Clinical Outcomes in Patients Who Have Undergone Donor Hematopoietic Stem Cell TransplantActive, not recruitingNCT03922035Phase 1
- Hypertension Management in Cancer PatientsTerminatedNCT03919214Not applicable
- RDD Versus VDD in Newly Diagnosed Patients With Multiple MyelomaStatus unknownNCT03908138Phase 4
- Pharmacokinetics of Ledipasvir/Sofosbuvir in Hepatitis C Virus-Infected Children With Hematological MalignancyCompletedNCT03903185Phase 1/2
- Detection of Bloodstream Pathogens in Hematological MalignanciesCompletedNCT03896880
- A Study of F0002-ADC in Chinese Patients With Refractory or Recurrent CD30+ Hematologic Malignancies.CompletedNCT03894150Phase 1
- Novel 3D Hematological Malignancy Organoid to Study Disease Biology and ChemosensitivityActive, not recruitingNCT03890614
- A Study of PRT543 in Participants With Advanced Solid Tumors and Hematologic MalignanciesCompletedNCT03886831Phase 1
- VPA Expanded UCB Transplantation for Treatment of Patients With Hematological MalignanciesCompletedNCT03885947Phase 1
- CLAGE Sequential With Flu-Bu Conditioning for Refractory Acute LeukemiaCompletedNCT03882203Phase 2
- Serial Measurements of Molecular and Architectural Responses to Therapy (SMMART) PRIME TrialTerminatedNCT03878524Phase 1
- Identifying Best Approach in Improving Quality of Life and Survival After a Donor Stem Cell Transplant in Older, Medically Infirm, or Frail Patients With Blood DiseasesTerminatedNCT03870750Phase 2/3
- Central Venous Access Device Removal in Cancer PatientsCompletedNCT03855969
- Infusion of Donor Derived Cytokine Induced Killer (CIK) Cells in Hematological Patients Relapsed After Haploidentical Stem Cell TransplantStatus unknownNCT03821519Phase 1/2
- Fecal Microbiota Transplantation for Steroid Resistant/Dependent Acute GI GVHDCompletedNCT03812705Phase 2
- Comprehensive Study of Social Representation of Platelet Transfusion in Patients Followed for Advanced Hematological Malignancies (R-PLQ)CompletedNCT03806712
- Psycho-Educational Cognition Intervention in Patients With Blood and Lymph CancerWithdrawnNCT03804164Not applicable
- Evolution of Thromboelastography During Tranexamic Acid TreatmentCompletedNCT03801122Phase 2
- Expressive Helping for Stem Cell Transplant PatientsCompletedNCT03800758Phase 3
- Early Palliative Care for Patients With Haematological MalignanciesStatus unknownNCT03800095Phase 3
- A Study of Venetoclax and AMG 176 in Patients With Relapsed/Refractory Hematologic MalignanciesTerminatedNCT03797261Phase 1
- CLL1-CD33 cCAR in Patients With Relapsed and/or Refractory, High Risk Hematologic MalignanciesStatus unknownNCT03795779Early Phase 1
- A Study of CC-95251, a Monoclonal Antibody Directed Against SIRPα, in Participants With Advanced Solid and Hematologic CancersTerminatedNCT03783403Phase 1
- Prophylactic Donor Lymphocyte Infusion After Allo-PBSCT for Patients With Very High-risk Hematologic MalignanciesStatus unknownNCT03771222Phase 2
- MS Detection of Somatic Mutations in Hematological MalignanciesStatus unknownNCT03771079
- A Phase I Study of YY-20394 in Patients With B Cell Hematologic MalignanciesStatus unknownNCT03757000Phase 1
- Economic Evaluation of Innovative Molecular Analyses in Onco-haematologyStatus unknownNCT03750994
- Early Palliative Care and Hematological Cancer PatientsTerminatedNCT03743480Not applicable
- Flotetuzumab in Treating Patients With Recurrent or Refractory CD123 Positive Blood CancerWithdrawnNCT03739606Phase 2
- Antibacterial Prophylaxis vs no Prophylaxis for Hematological Malignancies Patients Before Allo-HSCTStatus unknownNCT03733340Phase 2/3
- Blood Sample Collection to Evaluate Biomarkers in Subjects With Untreated Hematologic MalignanciesTerminatedNCT03727009
- Safety, Tolerability and Pharmacokinetics/Pharmacodynamics (PK/PD) of SHR-1603 in Subjects With Advanced MalignanciesSuspendedNCT03722186Phase 1
- Hématologie Adulte Prevalence of Adrenal Insufficiency Post-chemotherapy Adrenocorticotropia in Adult HematologyWithdrawnNCT03688789Not applicable
- Oxygenation Methods and Non-invasive Ventilation in Patients With Acute Respiratory Failure and a do Not Intubate OrderStatus unknownNCT03673631
- Fungal Infections in Patients With Hematological MalignanciesStatus unknownNCT03650439
- Ketamine-ketorolac Versus Fentanyl- Ketorolac I.M in Children During Bone Marrow BiopsyCompletedNCT03649334Phase 4
- Body Scan Activity on Bone Marrow Transplant Patients and Their CaregiversTerminatedNCT03611764Phase 1
- Study of Thiotepa and TEPA Drug Exposure in Pediatric Hematopoietic Stem Cell Transplant PatientsCompletedNCT03609840
- Study of Melphalan Drug Exposure in Pediatric Hematopoietic Stem Cell Transplant PatientsCompletedNCT03609827
- Study of Clofarabine and Fludarabine Drug Exposure in Pediatric Bone Marrow Transplantation (HCT)CompletedNCT03609814
- Nivolumab and Tocilizumab for Relapsed Hematological Malignancy Post-allogeneic TransplantTerminatedNCT03588936Phase 1
- Safety, Tolerability, and Pharmacokinetics of SHC014748M in Patients With Indolent B-Cell Hematologic MalignanciesStatus unknownNCT03588598Phase 1
- Levorphanol as a Second Line Opioid in Reducing Pain in Patients With CancerTerminatedNCT03579446Early Phase 1
- Characteristics and Dynamics of TCR Repertoire in Patients With Hematological Malignancies After Allo-HSCTCompletedNCT03575767
- A Pilot Trial of Atorvastatin in Tumor Protein 53 (p53) -Mutant and p53 Wild-Type MalignanciesActive, not recruitingNCT03560882Phase 1
- WB-EMS and Nutrition in Patients With Hematological MalignanciesStatus unknownNCT03556748Not applicable
- A Trial to Evaluate the Potential Impact of Renal Impairment on the Pharmacokinetics and Safety of CPX-351CompletedNCT03555955Phase 1
- Human Lysozyme Goat Milk in Treating Patients With Blood Cancer Undergoing Donor Stem Cell TransplantWithdrawnNCT03531281Phase 1
- Study of SRF231 in Patients With Advanced Solid and Hematologic CancersCompletedNCT03512340Phase 1
- Systematic and Mechanism-based Approach to Rational Treatment Trials of Blood CancerCompletedNCT03488641
- Trial of AB-110 in Adults With Hematologic Malignancies Undergoing Cord Blood TransplantationCompletedNCT03483324Phase 1
- Therapeutic Virtual Reality : Impact on the Management of Pain and Anxiety Related to Hematology Care (REVEH)CompletedNCT03483194Phase 2/3
- Unicentric Retrospective Analysis of a Cohort of 602 Young Adult and Adolescent Patients (AJA), Aged 15 to 30 Years, With Haematological Malignancies, and Managed Between 2000 and 2016CompletedNCT03469921
- Safety/PK Study of Gene Modified Donor T Cell Infusion in Children With Recurrent Hem Malignancies After Allo TransplantActive, not recruitingNCT03459170Phase 1
- Critical Care Outcomes of Hematologic Oncology PatientsActive, not recruitingNCT03449953
- Peripheral Blood Stem Cell Transplantation From Family Haploidentical Donors in Patients With Myelodysplastic Syndrome and Acute Leukemia Under Primary Prophylaxis With PosaconazoleCompletedNCT03434704Phase 2
- Comparing Different Methods for Collection of Comorbidity Data Per the HCT-CICompletedNCT03434561
- Haploidentical Hematopoietic Cell Transplantation for Children With Hematologic Malignancies and MyelodysplasiaActive, not recruitingNCT03431090Phase 1/2
- Len/Dex/DLI in Relapsed Multiple Myeloma After Allogeneic Stem Cell TransplantCompletedNCT03413800Phase 2
- Therapeutic Education in Physical Activity (ETAF)CompletedNCT03403075Not applicable
- Dose Escalation Study of Talquetamab in Participants With Relapsed or Refractory Multiple MyelomaActive, not recruitingNCT03399799Phase 1
- Systematic Evaluation by an Intensivist of Hematological Malignancy Patients Presenting With Acute Respiratory or Hemodynamic FailureCompletedNCT03399149
- Long Term Follow up of Subjects Exposed to Genetically Engineered T Cell ReceptorsTerminatedNCT03391791
- APG-1387 in Patients With Advanced Solid Tumors or Hematologic MalignanciesCompletedNCT03386526Phase 1
- UF-BMT-HSCT-001: A Non-Interventional Study Evaluating Diet in HSCT SurvivorsCompletedNCT03377010
- Impact of Pulmonary Follow-up After Stem Cell GraftCompletedNCT03349372
- Safety and Efficacy Evaluation of IM19 CellsStatus unknownNCT03344705Phase 1
- Efficacy and Safety of High Dose Vitamin D Supplementation in Patients Undergoing HSCTStatus unknownNCT03320915Phase 2
- GRAVITAS-119: Itacitinib in Combination With Calcineurin Inhibitor-Based Interventions for the Prophylaxis of Graft-Versus Host DiseaseTerminatedNCT03320642Phase 1
- Identification of Occupational Exposures in Acute Hematologic MalignancyCompletedNCT03316209
- Genomic Testing and Resulting Medical DecisionsCompletedNCT03301493
- Management and Outcomes of Anti-thrombotic Medication Use in ThrombocytopeniaStatus unknownNCT03288441
- Study to Assess Safety, Tolerability, Pharmacokinetics and Antitumor Activity of AZD4573 in Relapsed/Refractory Haematological MalignanciesCompletedNCT03263637Phase 1
- A Study of Intravenous and Oral Isavuconazonium Sulfate in Pediatric PatientsCompletedNCT03241550Phase 1
- Prospective Cohort Study Depending on the Use of Palliative Care for Advanced Stage of Cancer PatientsCompletedNCT03222258
- Clinical Implications of Azole-Resistant Aspergillosis in Hematological MalignancyCompletedNCT03221075
- A Study of MGD013 in Patients With Unresectable or Metastatic NeoplasmsCompletedNCT03219268Phase 1
- Exercise Capacity and Physical Activity Levels in Newly Diagnosed Hematologic Malignant PatientsCompletedNCT03212560
- Low-Flow vs. High-Flow Nasal Cannula for Hypoxemic Immunocompromised Patients During Diagnostic BronchoscopyActive, not recruitingNCT03168815Not applicable
- A Study of Nemtabrutinib (MK-1026) in Participants With Relapsed or Refractory Hematologic Malignancies (ARQ 531-101/MK-1026-001)Active, not recruitingNCT03162536Phase 1/2
- Nivolumab for Relapsed or Residual Haematological Malignancies After Allogeneic Stem Cell TransplantationStatus unknownNCT03146468Phase 2
- Dose Escalation Study of Teclistamab, a Humanized BCMA*CD3 Bispecific Antibody, in Participants With Relapsed or Refractory Multiple MyelomaActive, not recruitingNCT03145181Phase 1
- Effectiveness of High Flow Oxygen Therapy in Patients With Hematologic Malignancy Acute Hypoxemic Respiratory FailureCompletedNCT03133520Not applicable
- Mesenchymal Stem Cell Infusion in Haploidentical Hematopoietic Stem Cell Transplantation in Patients With Hematological MalignanciesCompletedNCT03106662Phase 3
- A Multiple Ascending Dose Study of MEDI7247 in Patients With Selected Relapsed/Refractory Hematological MalignanciesCompletedNCT03106428Phase 1
- Extended Analysis for Leukemia/Lymphoma TreatmentCompletedNCT03096821
- Antiminor Histocompatibility Complex (MiHA) T Cells for Patients With Relapsed Hematologic Malignancies Following Matched HSCT (Guided Lymphocyte Immunopeptide Derived Expansion)Status unknownNCT03091933Phase 1/2
- Shared Health Information System for Febrile NeutropeniaCompletedNCT03087227Not applicable